Home/Pipeline/Neurological CBA Portfolio Expansion

Neurological CBA Portfolio Expansion

Autoimmune Encephalitis, Paraneoplastic Neurological Syndromes

Development/CommercialActive

Key Facts

Indication
Autoimmune Encephalitis, Paraneoplastic Neurological Syndromes
Phase
Development/Commercial
Status
Active
Company

About EUROIMMUN

EUROIMMUN is a leading, revenue-generating diagnostics company with a core focus on serological testing for autoimmune, infectious, and neurological diseases. The company leverages a broad technology platform encompassing immunofluorescence assays (IFA), ELISA, and chemiluminescence immunoassays (ChLIA), supported by automated instruments. As a subsidiary of Revvity, Inc., it benefits from global commercial scale while continuing to innovate, particularly in the high-growth area of neurological autoantibody testing.

View full company profile